NasdaqGM - Nasdaq Real Time Price USD
Adicet Bio, Inc. (ACET)
0.7899
+0.0109
+(1.40%)
As of 2:50:05 PM EDT. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | -0.29 | -0.3 | -1.15 | -1 |
Low Estimate | -0.32 | -0.33 | -1.31 | -1.41 |
High Estimate | -0.22 | -0.22 | -0.96 | -0.73 |
Year Ago EPS | -0.33 | -0.34 | -1.33 | -1.15 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.37 | -0.33 | -0.35 | -0.34 |
EPS Actual | -0.33 | -0.34 | -0.32 | -0.31 |
Difference | 0.03 | -0.01 | 0.03 | 0.03 |
Surprise % | 9.59% | -2.15% | 9.86% | 7.74% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.29 | -0.3 | -1.15 | -1 |
7 Days Ago | -0.28 | -0.29 | -1.15 | -1.01 |
30 Days Ago | -0.32 | -0.33 | -1.25 | -0.88 |
60 Days Ago | -0.32 | -0.33 | -1.25 | -0.88 |
90 Days Ago | -0.38 | -0.4 | -1.37 | -1.1 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 4 | 2 |
Up Last 30 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | -- | -- | 1 | 2 |
Down Last 30 Days | -- | -- | 1 | 2 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ACET | 11.52% | 12.35% | 13.83% | 12.57% |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
Reiterates | Guggenheim: Buy to Buy | 3/21/2025 |
Reiterates | Citizens Capital Markets: Market Perform to Market Perform | 3/7/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/7/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/27/2025 |
Reiterates | JMP Securities: Market Perform to Market Perform | 2/6/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/5/2025 |
Related Tickers
BCYC Bicycle Therapeutics plc
8.32
+0.18%
BOLT Bolt Biotherapeutics, Inc.
0.3249
+7.05%
CYCC Cyclacel Pharmaceuticals, Inc.
1.3994
-16.20%
IGMS IGM Biosciences, Inc.
1.2650
+1.20%
NKTX Nkarta, Inc.
1.8200
+2.82%
ELEV Elevation Oncology, Inc.
0.3010
-1.28%
PASG Passage Bio, Inc.
0.4843
-2.95%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.9200
+0.34%
GLUE Monte Rosa Therapeutics, Inc.
4.6300
-0.22%
FDMT 4D Molecular Therapeutics, Inc.
3.9048
+0.90%